Loading company…
Olaris develops precision medicine tools using metabolomics and machine learning.
Based in Framingham, US, Olaris develops a metabolite profiling platform and in vitro diagnostics to help identify biomarkers of treatment response. Founded in 2013 by Elizabeth O'Day, it combines metabolomics and machine learning to support patient outcomes and treatment decisions. Its partners include Thermo Fisher Scientific, The Michael J. Fox Foundation For Parkinson’s Research (MJFF), Caraway Therapeutics and Loulou Foundation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in